Agenus Inc. (AGEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.75-0.12 (-2.04%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close5.87
Bid5.61 x 300
Ask5.96 x 200
Day's Range5.73 - 5.91
52wk Range2.61 - 7.49
1y Target EstN/A
Market Cap500.23M
P/E Ratio (ttm)-5.54
Avg Vol (3m)1,199,893
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Agenus to Report Third Quarter 2016 Financial Results on October 27, 2016; Conference Call to Follow

    LEXINGTON, Mass., Oct. 20, 2016 /PRNewswire/ -- Agenus Inc. (AGEN) will release its third quarter 2016 financial results before the market opens on Thursday, October 27, 2016. Agenus executives will host a conference call at 11 a.m. Eastern Time the same day. To access the live call, dial 1-877-870-4263 (U.S.) or 1-412-317-0790 (International) and ask to be joined into the "Agenus Third Quarter 2016 Earnings Call." The call will also be webcast and will be accessible from the Company's website at

  • Capital Cube3 days ago

    ETF’s with exposure to Agenus, Inc. : October 19, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Agenus, Inc. Here are 5 ETF’s with the largest exposure to AGEN-US. Comparing the performance and risk of Agenus, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Better Buy: Agenus Inc. vs. Bellicum Pharmaceuticals Inc.
    Motley Fool3 days ago

    Better Buy: Agenus Inc. vs. Bellicum Pharmaceuticals Inc.

    Which of these clinical-stage biotechs is the better pick for investors right now?